Israeli biotech firm CollPlant is trying to patent a technology that could be used to print organs for those in need of a transplant.
David Blech, once dubbed the “King of Biotech”, failed to persuade a U.S. appeals court to throw out his four-year prison term for securities fraud on the ground that his sentencing judge was biased.
Israeli women are breaking the glass ceiling in the lucrative and growing biomedical field, taking on more leadership roles than ever before.